Clinical Trial Update: Comparison of SBRTand Repeat TACE for HCC [NA]

View source ↗

Summary

Clinical trial update comparing SBRT and repeat TACE for hepatocellular carcinoma. The current study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Gangneung Asan Hospital | Conditions: HepatoCellular Carcinoma | NA | Status: UNKNOWN